Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · IEX Real-Time Price · USD
0.845
-0.046 (-5.11%)
Aug 19, 2022 3:04 PM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Selling, General & Admin
13.5514.938.592.292.46
Research & Development
23.937.8820.9514.1913.39
Operating Expenses
37.4552.8129.5416.4915.85
Operating Income
-37.45-52.81-29.54-16.49-15.85
Interest Expense / Income
-0-0.22-0.1600
Other Expense / Income
-0.320.89-1.33-0.96-0.66
Pretax Income
-37.13-53.48-28.06-15.53-15.19
Net Income
-37.13-53.48-28.06-15.53-15.19
Net Income Common
-37.13-53.48-28.06-15.53-15.19
Shares Outstanding (Basic)
2121611
Shares Outstanding (Diluted)
2121611
Shares Change
0.72%252.08%419.98%0.11%-
EPS (Basic)
-1.74-2.53-4.67-13.45-13.17
EPS (Diluted)
-1.74-2.53-4.67-13.45-13.17
Free Cash Flow Per Share
-1.77-1.98-4.46-13.21-12.14
EBITDA
-36.86-53.47-28.05-15.52-15.18
Depreciation & Amortization
0.270.230.170.010.01
EBIT
-37.13-53.7-28.22-15.53-15.19
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).